Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Mapatumumab> ?p ?o }
Showing triples 1 to 70 of
70
with 100 triples per page.
- Mapatumumab abstract "Mapatumumab (HGS-ETR1) is an experimental human monoclonal antibody undergoing clinical trials for the treatment of cancer.This drug was discovered by Cambridge Antibody Technology (CAT) and Human Genome Sciences, Inc. (HGS) as a result of the collaboration between the two companies in 1999 in exploitation CAT's phage display technology.Early work by CAT and HGS indicated that mapatumumab induced cell death in multiple tumour types both in vitro and in vivo.".
- Mapatumumab atcPrefix "none".
- Mapatumumab casNumber "658052-09-6".
- Mapatumumab wikiPageID "9700653".
- Mapatumumab wikiPageLength "7186".
- Mapatumumab wikiPageOutDegree "23".
- Mapatumumab wikiPageRevisionID "707384823".
- Mapatumumab wikiPageWikiLink Bortezomib.
- Mapatumumab wikiPageWikiLink Cambridge_Antibody_Technology.
- Mapatumumab wikiPageWikiLink Carboplatin.
- Mapatumumab wikiPageWikiLink Category:Experimental_cancer_drugs.
- Mapatumumab wikiPageWikiLink Category:Monoclonal_antibodies_for_tumors.
- Mapatumumab wikiPageWikiLink Clinical_trial.
- Mapatumumab wikiPageWikiLink Colorectal_cancer.
- Mapatumumab wikiPageWikiLink Combination_therapy.
- Mapatumumab wikiPageWikiLink Human.
- Mapatumumab wikiPageWikiLink Human_Genome_Sciences.
- Mapatumumab wikiPageWikiLink Liver_cancer.
- Mapatumumab wikiPageWikiLink Monoclonal_antibody.
- Mapatumumab wikiPageWikiLink Multiple_myeloma.
- Mapatumumab wikiPageWikiLink Neoplasm.
- Mapatumumab wikiPageWikiLink Non-Hodgkin_lymphoma.
- Mapatumumab wikiPageWikiLink Non-small-cell_lung_carcinoma.
- Mapatumumab wikiPageWikiLink Paclitaxel.
- Mapatumumab wikiPageWikiLink Phage_display.
- Mapatumumab wikiPageWikiLink Sorafenib.
- Mapatumumab wikiPageWikiLink TRAIL.
- Mapatumumab wikiPageWikiLink Tumor_necrosis_factor_receptor.
- Mapatumumab wikiPageWikiLinkText "Mapatumumab".
- Mapatumumab wikiPageWikiLinkText "mapatumumab".
- Mapatumumab atcPrefix "none".
- Mapatumumab c "6748".
- Mapatumumab casNumber "658052".
- Mapatumumab chemspiderid "none".
- Mapatumumab h "10408".
- Mapatumumab mabType "mab".
- Mapatumumab molecularWeight "151.89".
- Mapatumumab n "1800".
- Mapatumumab o "2092".
- Mapatumumab s "52".
- Mapatumumab source "u".
- Mapatumumab target "TRAIL-receptor".
- Mapatumumab type "mab".
- Mapatumumab verifiedfields "changed".
- Mapatumumab verifiedrevid "462100121".
- Mapatumumab wikiPageUsesTemplate Template:Cascite.
- Mapatumumab wikiPageUsesTemplate Template:Chemspidercite.
- Mapatumumab wikiPageUsesTemplate Template:Drugbankcite.
- Mapatumumab wikiPageUsesTemplate Template:Drugbox.
- Mapatumumab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Mapatumumab wikiPageUsesTemplate Template:Reflist.
- Mapatumumab subject Category:Experimental_cancer_drugs.
- Mapatumumab subject Category:Monoclonal_antibodies_for_tumors.
- Mapatumumab hypernym Antibody.
- Mapatumumab type ChemicalSubstance.
- Mapatumumab type Drug.
- Mapatumumab type Antibody.
- Mapatumumab type Chemical.
- Mapatumumab type Drug.
- Mapatumumab type ChemicalObject.
- Mapatumumab type Thing.
- Mapatumumab type Q8386.
- Mapatumumab comment "Mapatumumab (HGS-ETR1) is an experimental human monoclonal antibody undergoing clinical trials for the treatment of cancer.This drug was discovered by Cambridge Antibody Technology (CAT) and Human Genome Sciences, Inc. (HGS) as a result of the collaboration between the two companies in 1999 in exploitation CAT's phage display technology.Early work by CAT and HGS indicated that mapatumumab induced cell death in multiple tumour types both in vitro and in vivo.".
- Mapatumumab label "Mapatumumab".
- Mapatumumab sameAs Q6753781.
- Mapatumumab sameAs ماباتوموماب.
- Mapatumumab sameAs m.02ppkkh.
- Mapatumumab sameAs Q6753781.
- Mapatumumab wasDerivedFrom Mapatumumab?oldid=707384823.
- Mapatumumab isPrimaryTopicOf Mapatumumab.